Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.

PloS one - 1 Jan 2013

Dang Yiwu, Luo Dianzhong, Rong Minhua, Chen Gang

Abstract excerpt

Aberrant expression of microRNA-34a (miR-34a) has been reported to be involved in the tumorigenesis and progression of various classes of malignancies. However, its role in hepatocellular carcinoma (HCC) has not been completely clarified. In the current study, we have investigated the clinical significance and the in vitro contribution of miR-34a on biological functions of human HCCs. miR-34a expression in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Primers

Share to Liver Neoplasms

Share to MicroRNAs

Share to Polymerase Chain Reaction

Share to Proto-Oncogene Proteins c-met

Source

Open in PubMed Open full text

Identifiers

PMID: 23593387
DOI: 10.1371/journal.pone.0061054
PMCID: PMC3622605

Genes

MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.PMID 23593387Read ↗

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinomaSemantic proximity Read ↗

MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic PotentialSemantic proximity Read ↗

MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathwaySemantic proximity Read ↗

c-Myc-activated miR-3682-3p aggravates the metastasis and stemness in hepatocellular carcinoma cells by regulating PTEN/PI3K/AKT signalingSemantic proximity Read ↗

PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCCSemantic proximity Read ↗

MicroRNA-34 Family, Mechanisms of Action in Cancer: A ReviewSemantic proximity Read ↗

Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinomaSemantic proximity Read ↗

MicroRNA‐34a: A Key Regulator in the Hallmarks of Renal Cell CarcinomaSemantic proximity Read ↗

Frequent Downregulation of miR-34 Family in Human Ovarian CancersSemantic proximity Read ↗

Down-regulation of tumor suppressor miR-34a contributes to head and neck cancer by up-regulating MET oncogene and modulating tumor immune evasionSemantic proximity Read ↗

MicroRNAs and Long Non-coding RNAs in c-Met-Regulated CancersSemantic proximity Read ↗

Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA InterferenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.